SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull Corp (BULL) is seeing heightened volatility and intense social media discussion as traders speculate on potential earnings leaks and manipulation ahead of the company's latest quarterly report. The community remains deeply divided, with bulls pointing toward the firm's growth in customer assets and upcoming regulatory changes as long-term catalysts, while bears focus on rising operating expenses and persistent downward pressure on the share price.

Akari Therapeutics Plc is a clinical-stage biopharmaceutical company. It engages in the development and commercialization of therapeutics to treat orphan autoimmune and inflammatory diseases. The company was founded on October 7, 2004 and is headquartered in Tampa, FL.

Akari Therapeutics Plc - ADR

Akari Therapeutics

Akari Therapeutics is trending as the stock surges following positive preclinical data for its lead ADC candidate and continued momentum from its recent strategic merger. The community is actively discussing the stock's low float and the potential for a short squeeze as investors weigh the impact of new leadership against the company's history of significant valuation declines.

Deckers Outdoor Corp. engages in the business of designing, marketing, and distributing footwear, apparel, and accessories developed for both everyday casual lifestyle use and high performance activities. It operates through the following segments: UGG Brand, HOKA Brand, Teva Brand, Sanuk Brand, Other Brands, and Direct-to-Consumer. The UGG Brand segment offers a line of premium footwear, apparel, and accessories. The HOKA Brand segment sells footwear and apparel that offers enhanced cushioning and inherent stability with minimal weight, originally designed for ultra-runners. The Teva Brand segment focuses on the sport sandal and modern outdoor lifestyle category, such as sandals, shoes, and boots. The Sanuk Brand segment originated in Southern California surf culture and has emerged into a lifestyle brand with a presence in the relaxed casual shoe and sandal categories. The Other Brands segment includes the Koolaburra by UGG brand. The Direct-to-Consumer segment consists of retail stores and e-commerce websites. The company was founded by Douglas B. Otto in 1973 and is headquartered in Goleta, CA.

Deckers Outdoor Corp.

Deckers Outdoor Corp. is capturing significant market attention as investors weigh the company's strong brand performance from HOKA and UGG against concerns over supply chain headwinds and institutional downgrades. While community sentiment remains divided between bulls focused on solid revenue growth and buyback initiatives and bears concerned about weakening leadership and sector-wide competitive pressure, market participants are bracing for upcoming earnings to provide clarity on the stock's future trajectory.

Strive, Inc. engages in the provision of an asset management Bitcoin treasury. It is focused on maximizing value for shareholders, accumulating bitcoin and outperforming bitcoin over the long run. The company was founded by Arshia Sarkhani, Jackson Fairbanks, Arman Sarkhani, and Kyle Fairbanks on March 9, 2022 and is headquartered in Dallas, TX.

Strive Inc. - Ordinary Shares - Class A

Strive Inc.

Strive Inc. is seeing intense community focus as shareholders monitor a seven-month breakout attempt and significant institutional accumulation, including recent position increases by major asset managers. Traders are actively debating the company's daily dividend strategy and balance sheet expansion while keeping a close watch on potential legislative catalysts and volatility linked to Bitcoin's price action.

UP Fintech Holding Ltd. is an online brokerage firm that focuses on global investors. It provides an online trading platform that enables investors to trade in equities and other financial instruments on multiple exchanges around the world. The firm offers products and services, as well as a user experience to customers through its mobile first strategy. The company was founded by Tian Hua Wu in June 2014 and is headquartered in Singapore.

UP Fintech Holding Ltd - ADR

UP Fintech is facing significant volatility as investors react to potential regulatory penalties in China, fueling concerns about the stability of the company's overseas brokerage operations. While some traders view the resulting pullback as a buying opportunity given the company's strong revenue growth and client account expansion, others are bracing for further downside amid broader skepticism toward Chinese ADRs.

Workday, Inc. engages in the provision of development of enterprise cloud applications for finance and human resources. It delivers financial management, human capital management and analytics applications designed for companies, educational institutions, and government agencies. The company was founded by David A. Duffield and Aneel Bhusri in 2005 and is headquartered in Pleasanton, CA.

Workday Inc - Ordinary Shares - Class A

Workday Inc

Workday is trending after reporting strong quarterly results that surpassed earnings and revenue expectations, helping to alleviate concerns regarding the durability of enterprise software demand. The community is actively discussing the company's progress in AI integration and whether these results signal a stabilization for the broader software sector against the rising narrative of AI-driven disruption.

Futu Holdings Ltd. engages in the provision of digitalized financial services. It offers securities brokerage and wealth management products. The company was founded by Leaf Hua Li in December 2007 and is headquartered in Hong Kong.

Futu Holdings Ltd - ADR

Futu Holdings is trending as shares face heavy downward pressure following reports of a two-year regulatory crackdown in China targeting overseas trading platforms. The community is actively debating whether to buy the dip as a value play or avoid the stock entirely due to persistent geopolitical risks and regulatory uncertainty.

Olema Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of next generation targeted therapies for women’s cancers. Its product candidate, OP-1250, is a novel oral therapy with combined activity as both a complete ER antagonist, or CERAN, and a selective ER degrader, or SERD, which is believed to drive deeper, more durable responses than existing therapies. The company was founded by Cyrus L. Harmon and Peter J. Kushner on August 7, 2006 and is headquartered in San Francisco, CA.

Olema Pharmaceuticals Inc

Olema Pharmaceuticals is surging as the success of a competitor's late-stage trial for a similar breast cancer drug class validates the potential of its own pipeline and fuels intense speculation about a future buyout. Community members are actively debating the sustainability of the rally versus risks like dilution, while institutional ownership and the potential for a short squeeze remain key focal points.

Groupon, Inc. engages in the global scaled two-sided marketplace that connects consumers to merchants. It operates through the North America and International geographical segments. The company was founded by Andrew D. Mason, Eric Paul Lefkofsky, and Bradley A. Keywell in October 2008 and is headquartered in Chicago, IL.

Groupon Inc

Groupon is seeing a surge in investor attention as the community identifies a classic short squeeze setup, fueled by high short interest, a shrinking float due to aggressive share buybacks, and anticipation ahead of earnings. Traders are actively discussing the stock's potential for parabolic movement, drawing comparisons to other high-profile squeeze plays while monitoring key technical resistance levels for a potential breakout.

Zoom Communications, Inc. engages in the provision of a communications and collaboration platform. It operates through the following geographical segments: Americas, Asia Pacific, and Europe, Middle East, and Africa. The company was founded by Eric S. Yuan in 2011 and is headquartered in San Jose, CA.

Zoom Communications Inc. - Ordinary Shares - Class A

Zoom Video Communications, Inc.

Zoom is trending after reporting a quarterly earnings beat and raising its full-year guidance, bolstered by strong enterprise demand and a new $1 billion share buyback authorization. Community sentiment remains split, with bulls pointing to the company's robust cash position and strategic AI investments as a value opportunity, while bears remain skeptical of long-term growth prospects due to intense competition and stagnant price action.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Radiopharm Theranostics Highlights Phase 1 Pipeline, Eyes June RAD 101 Data at DB Conference

Radiopharm Theranostics (NASDAQ:RADX) outlined progress across its radiopharmaceutical pipeline and highlighted near-term clinical catalysts during a presentation at the 30th Deutsche Bank Depositary Receipts Virtual Investor Conference.

Chief Executive Officer Riccardo Canevari described the compa...

Radiopharm Theranostics Limited - Sponsored ADR (NASDAQ:RADX) Sees Significant Decrease in Short Interest

Radiopharm Theranostics Limited - Sponsored ADR (NASDAQ:RADX - Get Free Report) was the target of a significant decline in short interest in April. As of April 15th, there was short interest totaling...

Radiopharm Theranostics Limited - Sponsored ADR (NASDAQ:RADX) Sees Significant Growth in Short Interest

Radiopharm Theranostics Limited - Sponsored ADR (NASDAQ:RADX - Get Free Report) was the recipient of a significant increase in short interest during the month of March. As of March 31st, there was...

Radiopharm Theranostics Limited - Sponsored ADR (NASDAQ:RADX) Given Average Rating of "Moderate Buy" by Analysts

Shares of Radiopharm Theranostics Limited - Sponsored ADR (NASDAQ:RADX - Get Free Report) have earned a consensus recommendation of "Moderate Buy" from the four analysts that are presently covering...

Radiopharm Theranostics Signs Supply Deal With Siemens Healthineers For RAD101

(RTTNews) - Radiopharm Theranostics Ltd. (RADX) said Tuesday it has signed a supply agreement with Siemens Healthineers for RAD101, a novel imaging small molecule targeting fatty acid synthase (FASN) to diagnose suspected recurrent brain metastases from solid tumors...

Radiopharm Theranostics Shares RAD101 Phase IIb Update: 90% Hit Primary Endpoint in Brain Mets Study

Radiopharm Theranostics (NASDAQ:RADX) executives and clinical investigators highlighted new interim findings from the company's ongoing Phase IIb study of RAD101, a PET imaging tracer intended to...

Radiopharm Theranostics Limited - Sponsored ADR (NASDAQ:RADX) Given Average Rating of "Buy" by Brokerages

Shares of Radiopharm Theranostics Limited - Sponsored ADR (NASDAQ:RADX - Get Free Report) have been given an average recommendation of "Buy" by the five analysts that are covering the firm...

Radiopharm Theranostics Limited - Sponsored ADR (NASDAQ:RADX) Short Interest Update

Radiopharm Theranostics Limited - Sponsored ADR (NASDAQ:RADX - Get Free Report) was the recipient of a significant decline in short interest during the month of February. As of February 27th, there...

Radiopharm Theranostics Limited - Sponsored ADR (NASDAQ:RADX) Given Consensus Rating of "Buy" by Brokerages

Shares of Radiopharm Theranostics Limited - Sponsored ADR (NASDAQ:RADX - Get Free Report) have received a consensus rating of "Buy" from the five ratings firms that are currently covering the stock...

Radiopharm Theranostics Limited - Sponsored ADR (NASDAQ:RADX) Short Interest Up 112.6% in January

Radiopharm Theranostics Limited - Sponsored ADR (NASDAQ:RADX - Get Free Report) saw a significant growth in short interest in the month of January. As of January 30th, there was short interest...

Radiopharm Theranostics Ltd. operates as a pre-clinical and clinical research company. It focuses on the development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical need. The company is founded by Paul A. Hopper in 2021 headquartered Carlton, Australia.

RADX
Radiopharm Theranostics Ltd - ADR

Feed

News

Sentiment

Fundamentals

Info

Compact View

Latest RADX News

RADXRadiopharm Theranostics Ltd - ADR